Clinical efficacy of conbercept injection on neovascular age-related macular degeneration under different levels of inflammation
收藏数据链接：
官方服务：
资源简介：
Supplementary Tables
应用场景：
创建时间：
2023-09-09
相关数据集
Supplementary Material for: Anti-vascular endothelial growth factor treatment compared with steroid treatment for retinal vein occlusion: a meta-analysis
Background: This meta-analysis aims to compare the efficacy and safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents and intravitreal steroids for the treatment of macular
NIAID Data Ecosystem90
Model selection: comparison of the total residual deviance and DIC for Bayesian network meta-analyses with fixed or random treatment effects and baseline BCVA and/or CRT as covariates.
*Relative treatment effect for ranibizumab 0.5 mg PRN versus aflibercept 2.0 mg bi-monthly. BCVA, best-corrected visual acuity; CrI, credible interval; CRT, central retinal thickness; DIC, deviance in
NIAID Data Ecosystem50
Hypertensive disorders of pregnancy increase the risk of developing neovascular age-related macular degeneration in later life
Background: Hypertensive disorders of pregnancy (HDP) and short-term adverse outcomes have long been recognized; however, survivors remain at risk of long-term complications. We investigated whether H
Figshare2019-07-19 更新40
Influence of Anti-VEGFA and dexamathasone treatments on the early phase of cornea angiogenesis
Inflammation is a key component of pathological angiogenesis. Here we monitor gene expression profiles of the pre-sprouting phase of corneal angiogenesis in the rat model, as influenced by topically a
NIAID Data Ecosystem70
Effectiveness of monthly and fortnightly anti-VEGF treatments for age-related macular degeneration
ABSTRACT Purpose: To study the efficacy and safety of treatments with ranibizumab and bevacizumab for exudative age-related macular degeneration. Methods: A parallel randomized clinical trial was cond
Figshare2019-02-01 更新50
